| abstract |
The present invention provides compounds which exhibit an inhibitory effect on sodium-dependent glucose cotransporters. The invention also provides pharmaceutical compositions, methods of making the compounds, synthetic intermediates, and methods of using the compounds in combination with or independently of other therapeutic agents to treat diseases and disorders affected by SGLT inhibition. |